No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
APDN250117P5000
- 4.62
- 0.000.00%
15min DelayClose Mar 27 13:08 ET
0.00High0.00Low
0.00Open4.62Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-112.29%PremiumJan 17, 2025Expiry Date4.82Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.04Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced From Linea DNA
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday
10-K: FY2024 Annual Report
Applied DNA Sciences Announces Leadership Changes and Restructuring
Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments.